Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MF/F versus MF in children with persistent asthma
2009-010110-30Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mometasone and formoterol in asthma and persistent asthma (2 arms), sponsored by Merck & Co. Primary endpoint: Primary efficacy endpoint. Started Feb 2016; status: completed.
02
Drugs
mometasoneformoterol
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2009-010110-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010110-30.